
A price-target hike with training wheels
Susquehanna just raised its Intel price target from $45 to $65, which sounds dramatic until you notice the firm kept its rating at Neutral. Translation: “We think there’s more upside, but we’re not ready to bet the farm.”
The market’s already halfway to the party
Intel shares have been on a tear in April, trading near their 52-week high as analysts pile in around the company’s foundry and AI ambitions. The hype has been helped by chatter around partnerships and a broader re-rating of the stock — but at these levels, even the bulls are basically tapping the brakes and saying, “Don’t get too carried away.”
Why investors are still squinting at the fine print
The skepticism isn’t random. Intel’s last quarter showed revenue down 4.2% year over year, and the company has been operating with negative net margin and return on equity. Add in essentially no meaningful Q1 guidance and Wall Street’s still expecting roughly -$0.11 EPS for the year, and you’ve got a comeback story that’s exciting, but not exactly bulletproof.
Big picture: the bar got higher
For investors, the takeaway is simple: Intel has momentum, but momentum and durability are two very different gym memberships. A richer valuation means the next earnings report or execution slip could hit the stock harder than it used to. The bull case is alive — just not allowed to get sloppy.
